Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Asset Utilization Ratio (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Asset Utilization Ratio for 4 consecutive years, with 0.7 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio rose 385.68% to 0.7 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.7, a 385.68% increase, with the full-year FY2025 number at 0.55, up 293.84% from a year prior.
  • Asset Utilization Ratio was 0.7 for Q4 2025 at Phathom Pharmaceuticals, up from 0.6 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.7 in Q4 2025 to a low of 0.16 in Q1 2023.
  • A 4-year average of 0.14 and a median of 0.03 in 2024 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 101.41% in 2023, then soared 6789.17% in 2024.
  • Phathom Pharmaceuticals' Asset Utilization Ratio stood at 0.15 in 2022, then surged by 101.41% to 0.0 in 2023, then skyrocketed by 6789.17% to 0.14 in 2024, then surged by 385.68% to 0.7 in 2025.
  • Per Business Quant, the three most recent readings for PHAT's Asset Utilization Ratio are 0.7 (Q4 2025), 0.6 (Q3 2025), and 0.42 (Q2 2025).